Among main pathological types of NSCLC, identification of epidermal growth factor receptor (EGFR) mutation [3, 4], echinoderm microtubule-associated protein-like anaplastic lymphoma kinase (EML4-ALK) fusion [5, 6], and other genetic alterations bring revolutionary improvements to the treatment of advanced lung adenocarcinoma. Here, EGFR is linked to non-small cell lung carcinoma.